α,α-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells

被引:17
|
作者
Wang, M
Xu, ZD
Tu, PF
Yu, XL
Xiao, SL
Yang, M [1 ]
机构
[1] Peking Univ, Natl Res Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China
[2] Heibei Univ Sci & Technol, Dept Pharmaceut Chem, Shijiazhuang 050018, Peoples R China
基金
中国国家自然科学基金;
关键词
alpha; alpha-trehalose; guanidino groups; Tat-TAR interaction;
D O I
10.1016/j.bmcl.2004.02.073
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Replication of HIV-1 requires specific interactions of Tat protein with TAR RNA. Disruption of Tat TAR RNA interaction could inhibit HIV-1 replication. Here four target compounds were designed and synthesized to bind to TAR RNA for blocking the interaction of Tat-TAR RNA. The core molecule 6,6'-diamino-6,6'-dideoxy-alpha,alpha-trehalose was obtained from selective bromination of, alpha,alpha-trehalose at C-6,6', followed by acetylation, azide displacement, deacetylation, and reduction. Coupling of the core molecule with the protected amino acid, then deprotection and guanidinylation generated the novel alpha,alpha-trehalose derivatives. Their abilities to inhibit Tat-TAR RNA interaction in human cells were determined by a Tat-dependent HIV-1 LTR-driven CAT assays. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2585 / 2588
页数:4
相关论文
共 50 条
  • [1] Design and synthesis of á, á-trehalose derivatives bearing guanidino groups as inhibitors for the Tat Protein-TAR RNA interaction of HIV-1
    Wang Min Xu Zhidong Tu Pengfei Xiao Sulong Yu Xiaolin Yang Ming National Research Laboratory of Natural and Biomimetic Drugs Peking University Health Science Center Peking University Beijing P R China
    合成化学, 2004, (S1) : 45 - 45
  • [2] Synthesis and assay of isoquinoline derivatives as HIV-1 Tat-TAR interaction inhibitors
    He, MZ
    Yuan, DK
    Lin, W
    Pang, RF
    Yu, XL
    Yang, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (17) : 3978 - 3981
  • [3] Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition
    Alanazi, Awadh
    Ivanov, Andrey
    Kumari, Namita
    Lin, Xionghao
    Wang, Songping
    Kovalskyy, Dmytro
    Nekhai, Sergei
    VIRUSES-BASEL, 2021, 13 (10):
  • [4] 2-Phenylquinolones as Inhibitors of the HIV-1 Tat-TAR Interaction
    Gatto, Barbara
    Tabarrini, Oriana
    Massari, Serena
    Giaretta, Giulia
    Sabatini, Stefano
    Del Vecchio, Claudia
    Parolin, Cristina
    Fravolini, Arnaldo
    Palumbo, Manlio
    Cecchetti, Violetta
    CHEMMEDCHEM, 2009, 4 (06) : 935 - 938
  • [5] Unveiling RNA-Binding Properties of Verapamil and Preparation of New Derivatives as Inhibitors of HIV-1 Tat-TAR Interaction
    Martin, Celine
    De Piccoli, Serena
    Gaysinski, Marc
    Becquart, Cecile
    Azoulay, Stephane
    Di Giorgio, Audrey
    Duca, Maria
    CHEMPLUSCHEM, 2020, 85 (01): : 207 - 216
  • [6] The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction
    Chaloin, O
    Peter, JC
    Briand, JP
    Masquida, B
    Desgranges, C
    Muller, S
    Hoebeke, J
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (03) : 355 - 361
  • [7] Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors
    Chen, Shuguang
    Chen, Ran
    He, Meizi
    Pang, Ruifang
    Tan, Zhiwu
    Yang, Ming
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (05) : 1948 - 1956
  • [8] A novel quantitative bioassay for newly synthesized compounds as HIV-1 Tat-TAR RNA interaction inhibitors
    Yang, Ming
    He, Meizi
    Pang, Ruifang
    Zhang, Chunlei
    Yu, Fei
    Chen, Shuguang
    Yu, Xiaolin
    JOURNAL OF BIOTECHNOLOGY, 2008, 136 : S75 - S75
  • [9] The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction
    O. Chaloin
    J. -C. Peter
    J. -P. Briand
    B. Masquida
    C. Desgranges
    S. Muller
    J. Hoebeke
    Cellular and Molecular Life Sciences CMLS, 2005, 62 : 355 - 361
  • [10] Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors
    Pang, Ruifang
    Zhang, Chunlei
    Yuan, Dekai
    Yang, Ming
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (17) : 8178 - 8186